TY - JOUR
T1 - Current Practice of Airway Stenting in the Adult Population in Europe
T2 - A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)
AU - Dutau, Hervé
AU - Breen, David
AU - Bugalho, Antonio
AU - Dalar, Levent
AU - Daniels, Johannes
AU - Dooms, Christophe
AU - Eberhardt, Ralf
AU - Ek, Lars
AU - Encheva, Milena
AU - Febvre, Michel
AU - Hackl, Martin
AU - Marran, Sirje
AU - Papai-Szekely, Zsolt
AU - Perch, Michael
AU - Roglic, Mihovil
AU - Rosell, Antoni
AU - Rozman, Ales
AU - Shah, Pallav L
AU - Simon, Marioara
AU - Szlubowski, Artur
AU - Stratakos, Grigoris
AU - Sundset, Arve
AU - Uibu, Toomas
AU - Von Garnier, Christophe
AU - Zaric, Bojan
AU - Zdraveska, Marija
AU - Zuccatosta, Lina
AU - Bokan, Darijo
AU - Arshad Husain, Syed
AU - Bilaceroglu, Semra
AU - Gasche-Soccal, Paola
AU - Gasparini, Stefano
AU - Herth, Felix J F
AU - Munavvar, Muhammed
N1 - © 2017 S. Karger AG, Basel.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - BACKGROUND: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents.OBJECTIVES: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries.METHODS: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016.RESULTS: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not.CONCLUSION: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings.
AB - BACKGROUND: Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using different insertion techniques and different types of stents.OBJECTIVES: This study is an international survey conducted by the European Association of Bronchology and Interventional Pulmonology (EABIP) focusing on AS practice within 26 European countries.METHODS: A questionnaire was sent to all EABIP National Delegates in February 2015. National delegates were responsible for obtaining precise and objective data regarding the current AS practice in their country. The deadline for data collection was February 2016.RESULTS: France, Germany, and the UK are the 3 leading countries in terms of number of centres performing AS. These 3 nations represent the highest ranked nations within Europe in terms of gross national income. Overall, pulmonologists perform AS exclusively in 5 countries and predominately in 12. AS is performed almost exclusively in public hospitals. AS performed under general anaesthesia is the rule for the majority of institutions, and local anaesthesia is an alternative in 9 countries. Rigid bronchoscopy techniques are predominant in 20 countries. Amongst commercially available stents, both Dumon and Ultraflex are by far the most commonly deployed. Finally, 11 countries reported that AS is an economically viable activity, while 10 claimed that it is not.CONCLUSION: This EABIP survey demonstrates that there is significant heterogeneity in AS practice within Europe. Therapeutic bronchoscopy training and economic issues/reimbursement for procedures are likely to be the primary reasons explaining these findings.
KW - Bronchoscopy/instrumentation
KW - Europe
KW - Humans
KW - Pulmonary Medicine/instrumentation
KW - Stents/statistics & numerical data
KW - Surveys and Questionnaires
U2 - 10.1159/000480152
DO - 10.1159/000480152
M3 - Journal article
C2 - 28881352
SN - 0025-7931
VL - 95
SP - 44
EP - 54
JO - Respiration
JF - Respiration
IS - 1
ER -